| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 09/26/2006 | US7112568 an anti-allergic agent, comprising a molecule having at least a first segment competent for importation of the molecule into mast cells, and a second segment for having an anti-allergic effect within the mast cells |
| 09/26/2006 | US7112567 reactive entity (maleimide) coupled to the peptide conjugated to blood protein such as immunoglobulins, including IgG and IgM, serum albumin, ferritin, steroid binding proteins, transferrin, thyroxin binding protein, alpha -2-macroglobulin, haptoglobin, etc. |
| 09/26/2006 | US7112562 Insulin conjugates and methods of use thereof |
| 09/26/2006 | US7112438 Binding molecules for human factor VIII and factor VIII-like proteins |
| 09/26/2006 | US7112436 Conjugate for modifying interactions between proteins |
| 09/26/2006 | US7112426 Human cAMP-dependent protein kinase beta-catalytic subunit |
| 09/26/2006 | US7112425 Polynucleotides and polypeptides coded by said polynucleotides involved in the synthesis of diketopiperazine derivatives |
| 09/26/2006 | US7112421 Nucleic acids encoding BAFF receptor, chimeric proteins and methods and compositions related thereto |
| 09/26/2006 | US7112420 Lymphoma associated molecules and uses therefor |
| 09/26/2006 | US7112419 For suppression of hepatocellular carcinoma; genetic engineering |
| 09/26/2006 | US7112418 Ion channel |
| 09/26/2006 | US7112414 Masp-2, a complement-fixing enzyme, and uses for it |
| 09/26/2006 | US7112331 Vaccines against varicella zoster virus gene 63 product |
| 09/26/2006 | US7112329 useful in peptide-based immunotherapy for patients with spring tree pollinosis; diagnosis; |
| 09/26/2006 | US7112321 Amyothropic lateral sclerosis; gene therapy |
| 09/26/2006 | CA2345903C Molecular pathogenicide mediated plant disease resistance |
| 09/26/2006 | CA2283464C Functional dna clone for hepatitis c virus (hcv) and uses thereof |
| 09/26/2006 | CA2254953C Therapies for chronic renal failure |
| 09/26/2006 | CA2102624C Transmission-blocking vaccine against malaria |
| 09/21/2006 | WO2006099592A2 Mannose immunogens for hiv-1 |
| 09/21/2006 | WO2006099590A2 Modified clostridial toxins with altered targeting capabilities for clostridial toxin target cells |
| 09/21/2006 | WO2006099480A2 Stress proteins and peptides and methods of use thereof |
| 09/21/2006 | WO2006099108A2 Structure of the hepatitis c virus ns2 protein |
| 09/21/2006 | WO2006099037A2 A sporadic tumor mouse model for drug discovery |
| 09/21/2006 | WO2006099019A2 Methods and composition related to in vivo imaging of gene expression |
| 09/21/2006 | WO2006098793A2 Hslim modulates immune responses |
| 09/21/2006 | WO2006098764A2 Potassium channel blockers |
| 09/21/2006 | WO2006098758A2 Compositions, methods and kits relating to cthrc1, a novel modulator of collagen matrix |
| 09/21/2006 | WO2006098520A1 Screening method |
| 09/21/2006 | WO2006098488A1 Method of ameliorating symptom caused by mood disturbance |
| 09/21/2006 | WO2006098463A1 Polynucleic acid-binding substance |
| 09/21/2006 | WO2006098423A1 Polynucleotides imparting environmental stress-tolerance to plants |
| 09/21/2006 | WO2006098340A1 Molybdenum transporter and gene thereof |
| 09/21/2006 | WO2006098304A1 Novel secretory protein derived from pituitary cell and use of the same |
| 09/21/2006 | WO2006098087A1 Marker protein for use in diagnosis of pancreatic cancer |
| 09/21/2006 | WO2006098074A1 Apoptosis inducing agent for prostate carcinoma cell |
| 09/21/2006 | WO2006097944A2 Process for the purification of recombinant granulocyte-colony stimulating factor |
| 09/21/2006 | WO2006097732A2 Treatment of autoimmune and inflammatory diseases |
| 09/21/2006 | WO2006097708A2 Affinity purification of protein |
| 09/21/2006 | WO2006097694A2 Peptide synthesis supported by a soluble polymer |
| 09/21/2006 | WO2006097693A1 Convergent solid phase peptide synthesis by reaction of two fragments bound to solid support |
| 09/21/2006 | WO2006097682A1 Mechano growth factor peptides and their use |
| 09/21/2006 | WO2006097642A2 Composition comprising the n-terminal region of leishmania histone h2b, use thereof for inducing an immune response |
| 09/21/2006 | WO2006097636A1 Nucleic acid fragments and specific detection method by molecular identification of different bacteria species of the genus acinetobacter |
| 09/21/2006 | WO2006097538A1 Extended glp-1 compounds |
| 09/21/2006 | WO2006097537A2 Acylated glp-1 compounds |
| 09/21/2006 | WO2006097536A2 Dimeric peptide agonists of the glp-1 receptor |
| 09/21/2006 | WO2006097526A1 Compounds for use in the treatment of obesity |
| 09/21/2006 | WO2006097521A1 Pegylated single-chain insulin |
| 09/21/2006 | WO2006097464A1 Recombinant expression of defensins in filamentous fungi |
| 09/21/2006 | WO2006097336A2 A novel component of the wg/wnt signaling pathway |
| 09/21/2006 | WO2006097335A1 A new element of the wg/wnt signaling pathway |
| 09/21/2006 | WO2006097285A1 Hepatitis-b viral variants with reduced susceptibility to nucleoside analogs and uses thereof |
| 09/21/2006 | WO2006097284A1 Variants of hepatitis b virus resistant against some nucleoside analogues, but sensitive to others, and uses thereof |
| 09/21/2006 | WO2006097110A2 Polypeptides having antimicrobial activity and polynucleotides encoding same |
| 09/21/2006 | WO2006096953A1 Use of crotamine, kit and composition |
| 09/21/2006 | WO2006070023A3 Method for reversing multiple resistance in animal cells |
| 09/21/2006 | WO2006067232A3 Plants having increased yield and method for making the same |
| 09/21/2006 | WO2006059125A3 Tumour suppressor genes |
| 09/21/2006 | WO2006058300A3 Antibodies and peptide antigens for producing antibodies having a selective binding specificity to bioactive intact parathyroid hormone (pth) 1-84 |
| 09/21/2006 | WO2006043182A3 Screening assays for inhibitors of a staphylococcus aureus siderophore |
| 09/21/2006 | WO2006042848A3 Growth hormone conjugates |
| 09/21/2006 | WO2006017181A3 Methods and systems for predicting protein-ligand coupling specificities |
| 09/21/2006 | WO2005112988B1 Methods for treating and diagnosing cancer with wnt inhibitory factor-1 (wif-1) |
| 09/21/2006 | WO2005100383A8 Novel hiv+ infected cells targeting retroviral vectors and uses thereof for treatment of hiv infection |
| 09/21/2006 | WO2005090395A3 Methods for increasing protein polyethylene glycol (peg) conjugation |
| 09/21/2006 | WO2005089229A3 Vpac1 selective antagonists and their pharmacological methods of use |
| 09/21/2006 | WO2005077105A3 Reduction of hiv-1 replication by a mutant apolipoprotein b mrna editing enzyme-catalytic polypeptide-like 3 g (apobec3g) |
| 09/21/2006 | WO2005065339A3 Cell cycle genes and related methods of using |
| 09/21/2006 | WO2005058936A3 Dna sequence, and recombinant production of the grass pollen allergen lol p 4 |
| 09/21/2006 | WO2005047308A3 Peptide-based diagnostic reagents for sars |
| 09/21/2006 | WO2005026321A3 Protein o-sulfonation |
| 09/21/2006 | WO2005001057A3 Lactobacillus acidophilus nucleic acids encoding fructo-oligosaccharide utilization compounds and uses thereof |
| 09/21/2006 | WO2004108946A3 Crystals of herpes simplex virus 1 dna polymerase and/or herpes simplex virus 1 dna polymerase-like proteins and the use thereof |
| 09/21/2006 | WO2004089282A3 Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
| 09/21/2006 | WO2002050303A3 Protein-protein interactions |
| 09/21/2006 | US20060212971 Nucleotide sequences mediating male fertility and method of using same |
| 09/21/2006 | US20060212965 AXMI-018, AXMI-020, and AXMI-021, a family of delta-endotoxin genes and methods for their use |
| 09/21/2006 | US20060212961 Rice transposon gene |
| 09/21/2006 | US20060212957 TRANSGENIC NON-HUMAN MAMMAL WITH AN ONCOGENIC MUTANT OF THE c-Raf GENE 1 |
| 09/21/2006 | US20060212955 Transgenic mice containing lymphoid-specific GPCR gene disruptions |
| 09/21/2006 | US20060212953 Tr2, tr4, tr2/tr4 double knockouts and uses thereof |
| 09/21/2006 | US20060211848 Novel genes encoding proteins having prognostic, diagnostic, preventive, therapeutic and other uses |
| 09/21/2006 | US20060211846 Zinc finger binding domains for nucleotide sequence ANN |
| 09/21/2006 | US20060211768 Means for the modulation of processes mediated by retinoid receptors and compounds useful therefor |
| 09/21/2006 | US20060211647 Binding proteins comprising transduction domain operably linked to targeting signal peptide comprising high mobility group boxes; for treatment of mitochondrial diseases |
| 09/21/2006 | US20060211623 Conopeptides |
| 09/21/2006 | US20060211622 Isolated human nuclear hormone receptors, nucleic acid molecules encoding human nuclear hormone receptors, and uses thereof |
| 09/21/2006 | US20060211620 Nucleic acid constructs, recombinant expression vectors, and recombinant host cells comprising the polynucleotides |
| 09/21/2006 | US20060211619 Polypeptide having endopeptidase domain;translocation domain having more than one binding domain directed to a cell surface feature of a target cell; modified neurotoxins; to prevent exocytosis and secretion by the target cell; disorders of tsensory or motor nervous system, acute or chronic pain, cancer |
| 09/21/2006 | US20060211618 Polynucleotides and polypeptides of the erythropoietin gene |
| 09/21/2006 | US20060211616 Purification of glucagon-like peptides |
| 09/21/2006 | US20060211615 Surfactant peptide nanostructures, and uses thereof |
| 09/21/2006 | US20060211614 Methods of inhibiting angiogenesis with fragments and homologs of troponin subunit 1 |
| 09/21/2006 | US20060211610 Controlling biological activities such as cell proliferation, nutrient transport, lipolysis and intestinal water and electrolyte secretion; PYY agonists: obesity, antidiabetic agents, eating disorders; cardiovascular diseasse; PYY antagonist: facilitating weight gain and appetite increase |
| 09/21/2006 | US20060211609 Novel agent for improving neurotransmission failure |
| 09/21/2006 | US20060211607 Somatostatin-dopamine chimeric analogs |
| 09/21/2006 | US20060211601 Nitrosated and nitrosylated heme proteins |
| 09/21/2006 | US20060211150 Fibronectin and fibrinogen biopolymer markers indicative of insulin resistance |
| 09/21/2006 | US20060211149 Fibronectin and fibrinogen biopolymer markers indicative of insulin resistance |